Distinct expression and prognostic values of the replication protein A family in gastric cancer

Zhang,Yujie; Yu,Chaoran

doi:10.3892/ol.2020.11253

Distinct expression and prognostic values of the replication protein A family in gastric cancer

Authors:
- Yujie Zhang
- Chaoran Yu
View Affiliations

Affiliations: Department of Gastrointestinal Surgery, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Fudan University Shanghai Cancer Center, Fudan University, Shanghai 200025, P.R. China
Published online on: January 7, 2020 https://doi.org/10.3892/ol.2020.11253
Pages: 1831-1841
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The replication protein A (RPA)1‑4 family are single‑stranded DNA‑binding proteins that are essential components of DNA replication, repair and recombination, and cell cycle regulation. The present study aimed to evaluate the prognostic value of the RPA family members in patients with gastric cancer (GC), using datasets retrieved from the Oncomine public database. Datasets were retrieved for the purpose of comparing the RPA expression levels between GC and normal tissues. Additionally, Kaplan‑Meier analysis was used to compare the overall survival (OS) times of GC patients that expressed different levels of RPA proteins. RPA1, 2, and 3 expression levels were all significantly upregulated in gastric intestinal‑type, diffuse gastric, and gastric mixed adenocarcinomas, compared with those in normal mucosal tissues. Moreover, high mRNA expression levels of RPA3 and 4 predicted poorer OS times in all GCs, as well as patients with human epidermal growth factor receptor 2‑negative and ‑positive GC. The high‑risk group, separated by RPA signature, showed a poorer outcome than the low‑risk group. RPA3 was the most strongly correlated with CD4+ T‑cell levels. In conclusion, RPAs are novel prognostic indicators in GC, and can also predict the features of immunological diseases. Future experimental investigation into the roles of RPAs concerning the pathogenesis and development of GC may provide a novel biomarker or therapeutic target, improving the prognosis of patients with GC.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
2	Song Z, Wu Y, Yang J, Yang D and Fang X: Progress in the treatment of advanced gastric cancer. Tumour Biol. 39:10104283177146262017. View Article : Google Scholar : PubMed/NCBI
3	Mayer RJ, Venook AP and Schilsky RL: Progress against GI cancer during the American society of clinical oncology's first 50 years. J Clin Onco. 32:1521–1530. 2014. View Article : Google Scholar
4	Haring SJ, Humphreys TD and Wold MS: A naturally occurring human RPA subunit homolog does not support DNA replication or cell-cycle progression. Nucleic Acids Res. 38:846–858. 2010. View Article : Google Scholar : PubMed/NCBI
5	Dahai Y, Sanyuan S, Hong L, Di Z and Chong Z: A relationship between replication protein A and occurrence and prognosis of esophageal carcinoma. Cell Biochem Biophys. 67:175–180. 2013. View Article : Google Scholar : PubMed/NCBI
6	Kanakis D, Levidou G, Gakiopoulou H, Eftichiadis C, Thymara I, Fragkou P, Trigka EA, Boviatsis E, Patsouris E and Korkolopoulou P: Replication protein A: A reliable biologic marker of prognostic and therapeutic value in human astrocytic tumors. Hum Pathol. 42:1545–1553. 2011. View Article : Google Scholar : PubMed/NCBI
7	Levidou G, Gakiopoulou H, Kavantzas N, Saetta AA, Karlou M, Pavlopoulos P, Thymara I, Diamantopoulou K, Patsouris E and Korkolopoulou P: Prognostic significance of replication protein A (RPA) expression levels in bladder urothelial carcinoma. BJU Int. 108:E59–E65. 2011. View Article : Google Scholar : PubMed/NCBI
8	Givalos N, Gakiopoulou H, Skliri M, Bousboukea K, Konstantinidou AE, Korkolopoulou P, Lelouda M, Kouraklis G, Patsouris E and Karatzas G: Replication protein A is an independent prognostic indicator with potential therapeutic implications in colon cancer. Mod Pathol. 20:159–166. 2007. View Article : Google Scholar : PubMed/NCBI
9	D'Errico M, de Rinaldis E, Blasi MF, Viti V, Falchetti M, Calcagnile A, Sera F, Saieva C, Ottini L, Palli D, et al: Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer. 45:461–469. 2009. View Article : Google Scholar
10	Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R, Chan AS, Law S, Troyanskaya OG, Wong J, et al: Variation in gene expression patterns in human gastric cancers. Mol Biol Cell. 14:3208–3215. 2003. View Article : Google Scholar : PubMed/NCBI
11	Cho JY, Lim JY, Cheong JH, Park YY, Yoon SL, Kim SM, Kim SB, Kim H, Hong SW, Park YN, et al: Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res. 17:1850–1857. 2011. View Article : Google Scholar : PubMed/NCBI
12	Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM: ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
13	Lánczky A, Nagy Á, Bottai G, Munkácsy G, Szabó A, Santarpia L and Győrffy B: miRpower: A web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res Treat. 160:439–446. 2016. View Article : Google Scholar : PubMed/NCBI
14	Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A, Michalowski A and Green JE: A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. PLoS One. 6:e166942011. View Article : Google Scholar : PubMed/NCBI
15	Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, Tao J, Ward L, Koo JH, Gopalakrishnan V, Zhu Y, et al: Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet. 5:e10006762009. View Article : Google Scholar : PubMed/NCBI
16	Förster S, Gretschel S, Jöns T, Yashiro M and Kemmner W: THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling. Mod Pathol. 24:1390–1403. 2011. View Article : Google Scholar : PubMed/NCBI
17	Wang G, Hu N, Yang HH, Wang L, Su H, Wang C, Clifford R, Dawsey EM, Li JM, Ding T, et al: Comparison of global gene expression of gastric cardia and noncardia cancers from a high-risk population in China. PLoS One. 8:e638262013. View Article : Google Scholar : PubMed/NCBI
18	Busuttil RA, George J, Tothill RW, Ioculano K, Kowalczyk A, Mitchell C, Lade S, Tan P, Haviv I and Boussioutas A: A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal response. Clin Cancer Res. 20:2761–2772. 2014. View Article : Google Scholar : PubMed/NCBI
19	Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
20	Aguirre-Gamboa R, Gomez-Rueda H, Martínez-Ledesma E, Martínez-Torteya A, Chacolla-Huaringa R, Rodriguez-Barrientos A, Tamez-Peña JG and Treviño V: SurvExpress: An online biomarker validation tool and database for cancer gene expression data using survival analysis. PLoS One. 8:e742502013. View Article : Google Scholar : PubMed/NCBI
21	Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B and Liu XS: TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77:e108–e110. 2017. View Article : Google Scholar : PubMed/NCBI
22	Li B, Severson E, Pignon JC, Zhao H, Li T, Novak J, Jiang P, Shen H, Aster JC, Rodig S, et al: Comprehensive analyses of tumor immunity: Implications for cancer immunotherapy. Genome Biol. 17:1742016. View Article : Google Scholar : PubMed/NCBI
23	Bochkarev A and Bochkareva E: From RPA to BRCA2: Lessons from single-stranded DNA binding by the OB-fold. Curr Opin in Struct Biol. 14:36–42. 2004. View Article : Google Scholar
24	Zou Y, Liu Y, Wu X and Shell SM: Functions of human replication protein A (RPA): From DNA replication to DNA damage and stress responses. J Cell Physiol. 208:267–273. 2006. View Article : Google Scholar : PubMed/NCBI
25	Wang J, Yang T, Chen H, Li H and Zheng S: Oncogene RPA1 promotes proliferation of hepatocellular carcinoma via CDK4/Cyclin-D pathway. Biochem Biophys Res Commun. 498:424–430. 2018. View Article : Google Scholar : PubMed/NCBI
26	Qu C, Zhao Y, Feng G, Chen C, Tao Y, Zhou S, Liu S, Chang H, Zeng M and Xia Y: RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma. J Cell Mol Med. 21:2872–2883. 2017. View Article : Google Scholar : PubMed/NCBI
27	Xiao W, Zheng J, Zhou B and Pan L: Replication protein A 3 is associated with hepatocellular carcinoma tumorigenesis and poor patient survival. Dig Dis. 36:26–32. 2018. View Article : Google Scholar : PubMed/NCBI
28	Jekimovs C, Bolderson E, Suraweera A, Adams M, O'Byrne KJ and Richard DJ: Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: The good, the bad, and the promising. Front Oncol. 4:862014. View Article : Google Scholar : PubMed/NCBI
29	Mishra AK, Dormi SS, Turchi AM, Woods DS and Turchi JJ: Chemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer. Biochem Pharmacol. 93:25–33. 2015. View Article : Google Scholar : PubMed/NCBI
30	Patrone JD, Kennedy JP, Frank AO, Feldkamp MD, Vangamudi B, Pelz NF, Rossanese OW, Waterson AG, Chazin WJ and Fesik SW: Discovery of protein-protein interaction inhibitors of replication protein A. ACS Med Chem Lett. 4:601–605. 2013. View Article : Google Scholar : PubMed/NCBI
31	Shi W, Feng Z and Zhang J, Gonzalez-Suarez I, Vanderwaal RP, Wu X, Powell SN, Roti Roti JL, Gonzalo S and Zhang J: The role of RPA2 phosphorylation in homologous recombination in response to replication arrest. Carcinogenesis. 31:994–1002. 2010. View Article : Google Scholar : PubMed/NCBI
32	Dai Z, Wang S, Zhang W and Yang Y: Elevated expression of RPA3 is involved in gastric cancer tumorigenesis and associated with poor patient survival. Dig Dis Sci. 62:2369–2375. 2017. View Article : Google Scholar : PubMed/NCBI
33	Keshav KF, Chen C and Dutta A: Rpa4, a homolog of the 34-kilodalton subunit of the replication protein A complex. Mol Cell Biol. 15:3119–3128. 1995. View Article : Google Scholar : PubMed/NCBI